EP
BCYC

Eudaimonia Partners’s Bicycle Therapeutics BCYC Stock Holding History

Eudaimonia Partners’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-515
Closed -$15K – 465
2021
Q1 		$15K Buy
+515
New +$13.3K ﹤0.01% 1040

Other funds holding BCYC

TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Eudaimonia Partners's BCYC Position: Q2 2021 in Review

Eudaimonia Partners sold out of Bicycle Therapeutics (BCYC) in Q2 2021, closing a stake of 515 shares — an estimated $15K sold.

Eudaimonia Partners first reported a position in BCYC in Q1 2021 and held it in 1 quarter. The position peaked at $15K in Q1 2021. 54 funds tracked by Wall St. Rank hold BCYC as of Q2 2021.

  • Eudaimonia Partners reported no remaining Bicycle Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 515 Bicycle Therapeutics shares in Q2 2021, an estimated $15K.
  • Eudaimonia Partners first reported a position in Bicycle Therapeutics in Q1 2021 and held it in 1 quarter.
  • Eudaimonia Partners's Bicycle Therapeutics position peaked at $15K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.